BD SurePath™ Pap Test


 

  • Highest disease detection in the industry
  • Lowest Unsat rate in the industry
  • Low ASC-US rates1
  • And now, BD SurePath™ Liquid-based Pap test is FDA-approved for out-of-vial CT/GC testing!

 

Now physicians can have the convenience of FDA-approved one-vial testing for cervical cancer, Chlamydia and Gonorrhea with very accurate results.

When you use the BD SurePath™ Liquid-based Pap test in conjunction with the BD ProbeTec™ CT/GC Qx Amplified DNA assays for testing for Chlamydia trachomatis (CT) and Neisseria Gonorrhoeae (GC), you get the convenience and reliable test results you’ve come to expect from BD Diagnostics.

Why use BD ProbeTec™ CT/GC Assays?
  • Higher sensitivity
  • Competitive specificity
  • Fewer rejected samples due to blood, mucus, gels, or cell debris
  • One-vial testing. Convenient for physicians. More comfortable for patients
  • Minimal specimen volume
  • The only assays approved by the FDA for use with BD SurePath™ test

 

(Click for larger image)
 
* BD ProbeTec™ Chlamydia trachomatis Qx Amplified DNA Assay Package Insert 8081408
** BD ProbeTec™ Neisseria gonorrhoeae Qx Amplified DNA Assay Package Insert 8081400

For further information on using BD SurePath™ samples for CT/GC testing, contact your local BD representative or refer to the following package inserts:

References:
1 See BD PrepStain™ System Product Insert

 

Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2014 BD